Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84820 45222 15923 556
Operating income (EBITDA)11 21612 6164 9745 3025 5556 094
Operating profit (EBIT)9 0109 8334 0463 7154 1944 747
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 5322 9893 429
EPS ( $)3,013,721,621,281,872,19
Dividend per Share ( $)1,881,670,640,881,051,18
Yield4,43%3,93%1,51%2,07%2,46%2,77%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 6743 0865 3162 7602 951
Finance------
Operating income (EBITDA)11 21612 6164 9745 3025 5556 094
Leverage
(Debt/EBITDA)
0,77x0,77x0,62x1,00x0,50x0,48x
Capital Expenditure1 4921 7951 1451 0501 0881 250
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,1 $17,7 $18,7 $
Cash Flow per Share5,72 $5,85 $2,11 $3,20 $3,25 $3,55 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 63 847 M$ -
Entreprise Value (EV) 69 163 M$ 66 607 M$
Valuation 2014e 2015e
PER (Price / EPS) 33,2x 22,7x
Capitalization / Revenue 3,12x 2,88x
EV / Revenue 3,38x 3,01x
EV / EBITDA 13,0x 12,0x
Yield (DPS / Price) 2,07% 2,46%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,2% 18,9%
operating Leverage (Delta EBIT / Delta Sales) -1,28x 1,54x
Net Margin (Net Profit / Revenue) 12,4% 13,5%
ROA (Net Profit / Asset) 8,20% 7,55%
ROE (Net Profit / Equities) 12,7% 13,0%
Rate of Dividend 68,8% 55,9%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,13% 4,91%
Cash Flow / Sales (Taux d'autofinancement) 23,5% 22,0%
Capital Intensity (Assets / Sales) 1,51x 1,79x
Financial Leverage (Net Debt / EBITDA) 1,00x 0,50x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF